List view / Grid view

Bahija Jallal

 

article

Biologics: Teamwork pays off in race to expand market for monoclonal antibodies

The first biologic drug – infliximab (Remicade) – was launched…

22 October 2012 | By Bahija Jallal, Executive Vice President, Research & Development, MedImmune

The first biologic drug – infliximab (Remicade) – was launched in 1998 with initial sales of USD 500 million per annum. By 2010, Reuters’ top 10 drugs by sales included five biologics (Remicade, Enbrel, Humira, Avastin and Humira) generating around USD 34 billion in revenue, including USD 7.4 billion from…

article

Translational science: The future of medicine

When the term ‘translational medicine’ first came to prominence at…

16 February 2011 | By Bahija Jallal, Executive Vice President, Research & Development, MedImmune

When the term ‘translational medicine’ first came to prominence at the turn of the century, there were suspicions that this concept was simply a rebranding of conventional medical research, describing the process in which scientific discovery at the laboratory bench eventually translates to an effective therapy at the patient’s bedside.…